Sfoglia per AUTORE
MINA R
Collezione ASL Vercelli

  

Items : 6

Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts. in Annals of hematology / Ann Hematol. 2025 Feb 13. doi: 10.1007/s00277-025-06212-5.

2025
ASL Vercelli
AOU Città della Salute di Torino

Ria R; Mina R; Mele G; Liberatore C; Furlan A; Fazio F; Derudas D; Mangiacavalli S; De Paoli L; Martello M; D'Agostino M; Zamagni E;

Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy in Annals of Hematology

2025
ASL Vercelli

Conticello C; Fabro VD; Romano A; Mele A; Mina R; Bringhen S; Orofino A; Antonioli E; Pulini S; De Paoli L; Za T; Cotzia E; Elia F; Casson A; Prete E; Citiso S; Liberatore C; Margiotta-Casaluci G; Fazio F; Morè S; Attucci I; Accardi F; Bongarzoni V; Mangiacavalli S; Rossi E; Mannina D; Garibaldi B; Rizzi R; Di Cecca M; et alii...

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. in Blood / Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.

2013
AOU Città della Salute di Torino
ASL Vercelli

Larocca A; Montefusco V; Bringhen S; Rossi D; Crippa C; Mina R; Galli M; Marcatti M; La Verde G; Giuliani N; Magarotto V; Guglielmelli T; Rota-Scalabrini D; Omedé P; Santagostino A; Baldi I; Carella AM; Boccadoro M; Corradini P; Palumbo A;

Salvage treatment with pomalidomide-cyclophosphamideprednisone produces similar outcomes as compared to prior therapies in patients with relapsed/refractory multiple myeloma in Haematologica

2013
ASL Vercelli

Larocca A; Montefusco V; Oliva S; Spriano M; Santagostino A; Genuardi M; Rota-Scalabrini D; Guglielmelli T; Giuliani N; Moscetti A; Mina R; Marcatti M; Galli M; Gilestro M; Crippa C; Baldi I; Rossi D; Boccadoro M; Corradini P; Palumbo A;

Pomalidomide cyclophosphamide and prednisone is active in lenalidomide relapsed/ refractory multiple myeloma in Clinical Lymphoma, Myeloma and Leukemia

2013
ASL Vercelli

Larocca A; Montefusco V; Oliva S; Rossi D; Crippa C; Genuardi M; Galli M; Marcatti M; Moscetti A; Giuliani N; Mina R; Guglielmelli T; Rota-Scalabrini D; Oddolo D; Santagostino A; Baldi I; Spriano M; Boccadoro M; Corradini P; Palumbo A;

Pomalidomide cyclophosphamide and prednisone (PCP) treatment for relapsed/refractory multiple myeloma in Blood

2012
ASL Vercelli

Palumbo A; Larocca A; Montefusco V; Rossi D; Carella AM; Mina R; Crippa C; Sciacca M; Galli M; Scalabrini DR; Marcatti M; Guglielmelli T; Giuliani N; La Verde G; Baldi I; Muccio VE; Boccadoro M; Corradini P;